<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.0.2//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art502.dtd?><?SourceDTD.Version 5.0.2?><?ConverterInfo.XSLTName elsevier2nlm.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_AJHG212 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEmmc1 pdf ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id><journal-title>American Journal of Human Genetics</journal-title><issn pub-type="ppub">0002-9297</issn><issn pub-type="epub">1537-6605</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">AJHG212</article-id><article-id pub-id-type="doi">10.1016/j.ajhg.2008.07.004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Pathogenic Mitochondrial DNA Mutations Are Common in the General Population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Elliott</surname><given-names>Hannah R.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Samuels</surname><given-names>David C.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Eden</surname><given-names>James A.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Relton</surname><given-names>Caroline L.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Chinnery</surname><given-names>Patrick F.</given-names></name><email>p.f.chinnery@ncl.ac.uk</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib></contrib-group><aff id="aff1"><addr-line><sup>1</sup>Mitochondrial Research Group, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK</addr-line></aff><aff id="aff2"><addr-line><sup>2</sup>Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA</addr-line></aff><aff id="aff3"><addr-line><sup>3</sup>Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK</addr-line></aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>p.f.chinnery@ncl.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>08</day><month>8</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>01</day><month>8</month><year>2008</year></pub-date><volume>83</volume><issue>2</issue><fpage>254</fpage><lpage>260</lpage><history><date date-type="received"><day>2</day><month>6</month><year>2008</year></date><date date-type="rev-recd"><day>1</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>7</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2008 The American Society of Human Genetics. Published by Elsevier Ltd. All right reserved..</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>The American Society of Human Genetics</copyright-holder><license><p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p></license></permissions><abstract><p>Mitochondrial DNA (mtDNA) mutations are a major cause of genetic disease, but their prevalence in the general population is not known. We determined the frequency of ten mitochondrial point mutations in 3168 neonatal-cord-blood samples from sequential live births, analyzing matched maternal-blood samples to estimate the de novo mutation rate. mtDNA mutations were detected in 15 offspring (0.54%, 95% CI &#x0003d; 0.30&#x02013;0.89%). Of these live births, 0.00107% (95% CI &#x0003d; 0.00087&#x02013;0.0127) harbored a mutation not detected in the mother's blood, providing an estimate of the de novo mutation rate. The most common mutation was m.3243A&#x02192;G. m.14484T&#x02192;C was only found on sub-branches of mtDNA haplogroup J. In conclusion, at least one in 200 healthy humans harbors a pathogenic mtDNA mutation that potentially causes disease in the offspring of female carriers. The exclusive detection of m.14484T&#x02192;C&#x000a0;on haplogroup J implicates the background mtDNA haplotype in mutagenesis. These findings emphasize the importance of developing new approaches to prevent transmission.</p></abstract></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Disease-based epidemiological studies provide estimates of the minimum population prevalence of mtDNA disease as &#x0223c;1 in 5000,<xref rid="bib1 bib2 bib3 bib4 bib5 bib6" ref-type="bibr"><sup>1&#x02013;6</sup></xref> but the incidence of new mutations and the frequency of asymptomatic carriers have not been fully established. Fundamental differences between mtDNA inheritance and the Mendelian system mean that de novo mutation rates and carrier frequencies cannot be deduced with a standard Mendelian population-genetic approach. Strict maternal inheritance results in negligible intermolecular recombination apparent at the population level, and the presence of thousands of copies of mtDNA within each diploid mammalian cell adds a further complexity.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> Most pathogenic mtDNA mutations are heteroplasmic, with varying amounts of mutated mtDNA present within each cell.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Phenotypic expression is ultimately dependent upon the proportion of mutated mtDNA or the amount of wild-type mtDNA within vulnerable tissues. This only leads to a biochemical defect of the respiratory chain when a critical threshold level is exceeded, with the precise amount varying from mutation to mutation.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> In keeping with this, a family with mitochondrial disease usually presents clinically for the first time when an individual inherits a high proportion of mutated mtDNA from a mother who harbors a low level of mutated mtDNA and remains asymptomatic. Such dramatic changes in heteroplasmy can occur in a single generation because of a restriction in the intracellular mtDNA content during embryonic development that is responsible for the mtDNA genetic bottleneck.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref></p><p>Previous estimates of the carrier frequency of mtDNA mutations were largely based on the ascertainment of pedigrees through one or more clinically affected individuals, followed by careful family tracing of the maternal lineage.<xref rid="bib1 bib2 bib3 bib4 bib5 bib6" ref-type="bibr"><sup>1&#x02013;6</sup></xref> This raises the possibility that de novo mtDNA mutations remain undetected in the population because they are well below the threshold required for phenotypic expression or because they lie below the detection threshold of conventional sequencing. Many of these mutations would be lost through random genetic drift, causing disease only when the percentage level of mutation drifts upwards in one or more family members and exceeds the threshold required for clinical presentation.</p><p>A further complication is the strong association between specific pathogenic mtDNA mutations and closely related mtDNA polymorphisms (haplogroups), which is not thought to be due to a founder effect.<xref rid="bib10 bib11" ref-type="bibr"><sup>10,11</sup></xref> However, it is not known whether the polymorphisms that define the haplogroup predispose it to de novo mutation events, whether they cause the preferential segregation of pathogenic mutations, or whether they affect clinical expression of the associated disorder. The only way of addressing these issues is by screening a large random sample of the population, with matched maternal samples, to determine whether the detected mutations are de novo or inherited.</p></sec><sec sec-type="materials-methods" id="sec2"><title>Material and Methods</title><p>We measured the frequency of the ten pathogenic mtDNA mutations often found in patients with mitochondrial disease (m.1555A&#x02192;G, m.3243A&#x02192;G, m.3460G&#x02192;A, m.7445A&#x02192;G, m.8344A&#x02192;G, m.8993T&#x02192;G, m.11778G&#x02192;A, m.13513G&#x02192;A, m.14459G&#x02192;A, m.14484T&#x02192;C) in &#x0223c;3000 sequential umbilical-cord-blood samples from north Cumbria in England.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Consent for inclusion into the study exceeded 80%. Ethical approval to investigate mtDNA mutations within this cohort was granted by the West Cumbria Local Research Ethics Committee (Project 381). Previous epidemiological and nuclear genetic studies established that this cohort is a random sample of the population with numerous nuclear alleles in Hardy-Weinberg equilibrium.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref></p><sec id="sec2.1"><title>Haplogroup Determination</title><p>The ten major European mtDNA haplogroups were determined in 344 random samples from the cohort as described in the literature,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> with the use of modified primer sequences. This confirmed that the study group was representative of the UK population (<xref rid="tbl1" ref-type="table">Table 1</xref>). Mitochondrial haplogroups were also determined in samples that harbored mtDNA point mutations and in their mothers, with the same approach used.</p></sec><sec id="sec2.2"><title>High-Throughput Genotyping</title><p>The population was genotyped by primer extension of multiplex PCR products with the detection of the allele-specific extension products by matrix-associated laser desorption/ionization time of flight (MALDI-TOF; Sequenom MassARRAY, San Diego, CA). Assays were designed with Sequenom Assay Design software v2.0.7.0, resulting in five multiplex assays. The allelotyping assay was followed according to manufacturer's instructions, with modifications. At the primary PCR step, DNA was amplified under the following conditions: initial denaturation of 95&#x000b0;C for 15 minutes, then 30 cycles of denaturation at 95&#x000b0;C for 20 seconds, annealing at 60&#x000b0;C for 30 seconds, and extension at 72&#x000b0;C for 1 minute. Finally, there was a further extension at 72&#x000b0;C for 3 minutes before the samples were cooled and stored at 4&#x000b0;C. A homogeneous MassEXTEND (hME) reaction mix containing appropriate hME EXTEND mix (1&#x000d7; buffer with 0.225 mM d/ddNTPs), 2.7 &#x003bc;M MassEXTEND primer, and 0.576 U ThermoSequenase (GE Healthcare), made up to a final volume of 2 &#x003bc;L with anH<sub>2</sub>O, was added to each SAP-cleaned PCR product. The microplate was then thermocycled as follows: initial denaturation of 94&#x000b0;C for 2 minutes, then 55 cycles of denaturation at 94&#x000b0;C for 5 seconds, annealing at 52&#x000b0;C for 5 seconds, and extension at 72&#x000b0;C for 5 seconds before cooling to 4&#x000b0;C. The sample microplate and a 384 SpectroCHIP were loaded onto the deck of the Samsung Nanodispenser. 15 nL of solution from the sample microplate was transferred onto the chip, which was read by a Bruker Autoflex Mass Spectrometer system. Data was collected with the use of SpectroACQUIRE v3.3.1.3 software and visualised with the use of MassARRAY Typer v3.4 TyperAnalyzer software. The sensitivity of the MALDI-TOF MS assay for each mutation was assessed with mixed cloned mtDNA fragments in duplicate for both uniplex and multiplex reactions (<xref rid="app2" ref-type="sec">Table S1</xref>, available online).</p><p>The assay detected &#x02265; 10% mutated mtDNA in each case, and for some mutations, the detection threshold was considerably lower (<xref rid="app2" ref-type="sec">Table S1</xref>). For nine mutations, positive calls were confirmed by direct sequencing and last-cycle fluorescent PCR-RFLP from an independent aliquot of DNA, which established the percentage mutated mtDNA (see below). The m.1555A&#x02192;G mutation was confirmed by cloning and sequencing from a separate aliquot of DNA from the same subject.</p></sec><sec id="sec2.3"><title>Measurement of mtDNA Heteroplasmy</title><p>Positive calls were confirmed in an independent aliquot from the original DNA sample with the use of last-cycle fluorescent PCR-RFLP as described previously.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> This also established the percentage mutated mtDNA. For the m.1555A&#x02192;G mutation, heteroplasmy was quantified by cloning and sequencing of 23 independent mtDNA fragments from an independent aliquot from the original DNA sample. Primers and restriction enzymes and digests are shown in <xref rid="app2" ref-type="sec">Table S2</xref>.</p></sec><sec id="sec2.4"><title>MtDNA Sequencing</title><p>The mitochondrial noncoding control region (D-loop) was sequenced by PCR of four overlapping segments, with the use of forward and reverse M13-tagged primer pairs. Primer sequences are shown in <xref rid="app2" ref-type="sec">Table S3</xref>. PCR products were treated with ExoSAP (ExoSAP-IT, GE Healthcare, USA) and sequenced on a fluorescent genetic analyzer (Beckman-Coulter CEQ 8000) with the standard dideoxy chain-termination method (Beckman-Coulter Quickstart). The sequence data were compared to the revised Cambridge reference sequence (rCRS)<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> with the use of CEQ Sequence Analysis v2.3.13 analysis software (Beckman-Coulter). This allowed identification of D-loop changes and comparison of positive samples.</p></sec><sec id="sec2.5"><title>Statistical Analysis</title><p>Frequencies were compared by calculation of empirical P-values with a Monte Carlo-based simulation approach based on the method of Roff and Bentzen.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Exact 95% confidence intervals were calculated by the Clopper-Pearson method.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref></p></sec></sec><sec id="sec3"><title>Results</title><sec id="sec3.1"><title>Population Prevalence</title><p>Known duplicate samples from the same individual were 100% concordant. mtDNA mutations were detected in 15 different subjects (<xref rid="tbl2" ref-type="table">Table 2</xref>), giving a total mean frequency of 0.54% for the ten mutations (95% CI &#x0003d; 0.30&#x02013;0.89%) in neonatal-cord-blood samples. The m.3243A&#x02192;G mutation was the most common. No positive calls were seen for five mutations: m.7445A&#x02192;G, m.8344A&#x02192;G, m.8993T&#x02192;G, m.13513G&#x02192;A, and m.14459G&#x02192;A. In each case, the mutation was confirmed by an independent technique from a fresh aliquot of the source DNA, which was kept in a different laboratory. For the majority of mutations, this was performed with last-cycle fluorescent PCR/RFLP, as described in the <xref rid="sec2" ref-type="sec">Material and Methods</xref> section. For m.1555A&#x02192;G, the presence of the mutation was confirmed in each case by cloning and sequencing 23 independent clones.</p><p>Twelve subjects harbored a heteroplasmic mtDNA mutation. The mean heteroplasmy level for the 15 positive cases was 43% when homoplasmic mutations were included and 29% when homoplasmic mutations were excluded. The percentage level of mutant mtDNA was evenly distributed above and below the mean (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>). The three homoplasmic subjects, including two known siblings, harbored an LHON mutation. D-loop sequencing and mtDNA haplogroup analysis confirmed that other mutation-positive cases were not maternally related to each other or to known pedigrees from the same geographic region, which had a different mtDNA sequence at two or more sites<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> (<xref rid="tbl3" ref-type="table">Table 3</xref>).</p></sec><sec id="sec3.2"><title>Mutations Not Present in Maternal Samples</title><p>No matched maternal sample was available for seven of the positive cases, but in eight cases it was possible to study a maternal blood sample taken at the time of delivery of the offspring. mtDNA mutations were not detectable in the blood of three mothers, with one harboring m.11778G&#x02192;A, and two harboring m.3243A&#x02192;G. This provides an approximation of the de novo mutation for&#x000a0;mtDNA defects at 107/100,000 live births (95% CI &#x0003d; 87&#x02013;127). Two of the mothers, accounting for the three homoplasmic offspring with LHON mutations, were also homoplasmic for the mtDNA mutation.</p></sec><sec id="sec3.3"><title>MtDNA Haplogroup Association</title><p>When the carriers of mtDNA mutations were studied together, the frequency of the major European haplogroups was no different from the background population (Haplogroup H, p &#x0003d; 1.0; J, p &#x0003d; 0.1; U including subgroup K, p&#x000a0;&#x0003d; 0.1; T, p &#x0003d; 1). However, all of the m.14484T&#x02192;C carriers belonged to haplogroup J (p &#x0003d; 0.011, based on a comparison of the two index cases to the background-population data in <xref rid="tbl1" ref-type="table">Table 1</xref>). This was not the case for the other two LHON mutations, m.3460G&#x02192;A and m.11778A&#x02192;G. Subhaplogroup analysis of the two m.14484T&#x02192;C pedigrees on the basis of mtDNA D-loop sequencing (<xref rid="tbl3" ref-type="table">Table 3</xref>) showed that one family belonged to J2a (siblings 4607-1 and 0493-1 harbored m.16069T, m.16126C, m.150T, m.152C, m. 195C, m.16145A, and m.16231C) and the other to J1c (02966 harbored m.16069T, m.16126C, m.462T, and m.228A but is wild-type at m.152, m16145, m.16222, and m.16261).<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref></p></sec></sec><sec id="sec4"><title>Discussion</title><p>Previous studies were based on ascertainment through clinically affected subjects,<xref rid="bib1 bib2 bib3 bib4 bib5 bib6" ref-type="bibr"><sup>1&#x02013;6</sup></xref> were focused on one specific mutation,<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> and studied unrelated older subjects<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> in whom somatic mutation or mutation loss through segregation are potential confounding factors. We studied randomly ascertained neonatal-cord-blood samples in which the percentage level of mutation is likely to be at its highest level.<xref rid="bib15 bib21 bib22" ref-type="bibr"><sup>15,21,22</sup></xref> By studying ten-point mutations in &#x0223c;3000 subjects, we detected a pathogenic mtDNA mutation in &#x0003e; 1/200 live births. It is unlikely that the high frequency of&#x000a0;mtDNA mutations detected in the general population in this study was due solely to the use of a sensitive technique, because other mutation-specific studies reported a similar level of sensitivity (&#x0223c;2&#x02013;3% for m.3243A&#x02192;G<xref rid="bib2 bib5 bib23" ref-type="bibr"><sup>2,5,23</sup></xref>). It is also unlikely that our positive results were due to crosscontamination, because we confirmed each result using a different method on an independent aliquot of the source DNA, which was kept in another laboratory; we saw no evidence of heteroplasmy on the haplogroup RFLP assays; and, finally, we saw no heteroplasmic nucleotides on the D-loop sequence trace for each positive case. It is conceivable that, in some subjects, we did not detect an mtDNA mutation because the level of heteroplasmy either fell below the sensitivity of our high-throughput screening assay or was at higher percentage levels in other tissues. Our observations, therefore, provide a minimum figure for the prevalence of ten pathogenic mutations and indicate that mtDNA mutations are amongs the most common pathogenic alleles in the general population.</p><p>Although m.7445A&#x02192;G, m.8344A&#x02192;G, m.8993T&#x02192;G, m.13513G&#x02192;A, and m.14459G&#x02192;A were not detected, these mutations are also uncommon in mitochondrial-disease patients from the same UK population.<xref rid="bib3 bib6" ref-type="bibr"><sup>3,6</sup></xref> By contrast, the most common heteroplasmic mutation was m.3243A&#x02192;G (33%), reaching frequencies similar to that described in one mutation-specific survey.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> m.3243A&#x02192;G is also the most common heteroplasmic mtDNA mutation in adults with mtDNA disease from the same geographic region (40%).<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Therefore, a high mutation rate provides the likely explanation for the prevalence of m.3243A&#x02192;G in disease cohorts. By contrast, the carrier frequencies of the three major mutations that cause Leber hereditary optic neuropathy (LHON), m.3460G&#x02192;A, m.11778G&#x02192;A, and m.14484T&#x02192;C, were equal. This differs from the distribution for independent families with LHON in the north of England, where the majority of cases harbor the m.11778G&#x02192;A mutation (60%).<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> All of the asymptomatic m.14484T&#x02192;C carriers belonged to mtDNA haplogroup J. This is in keeping with the well-established preferential association between haplogroup J and m.14484T&#x02192;C LHON pedigrees ascertained through clinically affected individuals.<xref rid="bib24 bib25" ref-type="bibr"><sup>24,25</sup></xref> However, the data shown here provide the first direct evidence that this association is not due solely to enhanced clinical expression on J, as&#x000a0;previously thought.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Subhaplogroup analysis by mtDNA D-loop sequencing confirmed the independent recurrence of m.14484T&#x02192;C in asymptomatic carriers within the population, providing independent evidence that haplogroup J predisposes the mitochondrial genome to mutate at np.14484, possibly through near-neighbor effects as previously described to occur during mtDNA evolution.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref></p><p>In the heteroplasmic carriers, heteroplasmy levels were evenly distributed above and below the mean, as expected from population-genetic theory based on neutral alleles.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> Of the heteroplasmic offspring with matched maternal samples, the proportion of mutated mtDNA increased with transmission in each case. Although this could be evidence of genetic selection during transmission, the percentage level of m.3243A&#x02192;G in blood decreases exponentially during life,<xref rid="bib15 bib21 bib22" ref-type="bibr"><sup>15,21,22</sup></xref> so it is highly likely that some of these mothers originally had higher levels of m.3243A&#x02192;G, making it difficult to draw firm conclusions. In &#x0003e; 1 in 1000 live births, an mtDNA mutation was present in cord blood from the child but not detectable in the mother's blood, providing an estimation of the de novo mutation rate. It is conceivable that the maternal levels of heteroplasmy were below the detection threshold of the assay, possibly because the level of mutation in blood decreased during the mother's life.<xref rid="bib15 bib21 bib22" ref-type="bibr"><sup>15,21,22</sup></xref> However, the level of sensitivity for fluorescent PCR-RFLP is in the region of 1.8%,<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> making this unlikely.</p><p>Detecting heteroplasmic mtDNA mutations in &#x0003e;1 in 200 individuals of the background population has implications for studies reporting mtDNA mutations in specific disease groups. Our data show that putative disease associations, such as the reported high frequency of m.3243A&#x02192;G in diabetes mellitus,<xref rid="bib23 bib29 bib30 bib31" ref-type="bibr"><sup>23,29&#x02013;31</sup></xref> could be a chance finding irrelevant to pathogenesis. We have identified a massive reservoir of pathogenic mtDNA mutations in the general population, placing greater emphasis on developing techniques to prevent the transmission of pathogenic alleles that could segregate to high levels and thus cause mtDNA diseases in subsequent generations.</p></sec><sec id="app1" sec-type="supplementary-material"><title>Supplemental Data</title><p>Supplemental data include three tables and can be found with this article online at <ext-link xlink:href="http://www.ajhg.org/" ext-link-type="uri">http://www.ajhg.org/</ext-link>.</p></sec><sec id="app2" sec-type="supplementary-material"><title>Supplemental Data</title><p><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Three Tables</title></caption><media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></p></sec></body><back><ack><title>Acknowledgments</title><p>This work was principally funded by the United Mitochondrial Diseases Foundation, with additional support from the Association Fran&#x000e7;aise contre les Myopathies. P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science who also receives funding from the EU FP6 program, EUmitocombat and MITOCIRCLE, the Parkinsons Disease Society (UK), and the Medical Research Council (UK). The authors are grateful for technical assistance from Jocelyn Davies and expert advice given by Simon Pearce and John Burn.</p></ack><ref-list><title>References</title><ref id="bib1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skladal</surname><given-names>D.</given-names></name><name><surname>Halliday</surname><given-names>J.</given-names></name><name><surname>Thorburn</surname><given-names>D.R.</given-names></name></person-group><article-title>Minimum birth prevalence of mitochondrial respiratory chain disorders in children</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>1905</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">12805096</pub-id></citation></ref><ref id="bib2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majamaa</surname><given-names>K.</given-names></name><name><surname>Moilanen</surname><given-names>J.S.</given-names></name><name><surname>Uimonen</surname><given-names>S.</given-names></name><name><surname>Remes</surname><given-names>A.M.</given-names></name><name><surname>Salmela</surname><given-names>P.I.</given-names></name><name><surname>Karppa</surname><given-names>M.</given-names></name><name><surname>Majamaa-Volti</surname><given-names>K.A.M.</given-names></name><name><surname>Rusanen</surname><given-names>H.</given-names></name><name><surname>Sorri</surname><given-names>M.</given-names></name><name><surname>Peuhkurinen</surname><given-names>K.J.</given-names></name></person-group><article-title>Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population</article-title><source>Am. J. Hum. Genet.</source><year>1998</year><volume>63</volume><fpage>447</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">9683591</pub-id></citation></ref><ref id="bib3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Johnson</surname><given-names>M.A.</given-names></name><name><surname>Wardell</surname><given-names>T.M.</given-names></name><name><surname>Singh-Kler</surname><given-names>R.</given-names></name><name><surname>Hayes</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>D.T.</given-names></name><name><surname>Taylor</surname><given-names>R.W.</given-names></name><name><surname>Bindoff</surname><given-names>L.A.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name></person-group><article-title>Epidemiology of pathogenic mitochondrial DNA mutations</article-title><source>Ann. Neurol.</source><year>2000</year><volume>48</volume><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">10939569</pub-id></citation></ref><ref id="bib4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darin</surname><given-names>N.</given-names></name><name><surname>Oldfors</surname><given-names>A.</given-names></name><name><surname>Moslemi</surname><given-names>A.R.</given-names></name><name><surname>Holme</surname><given-names>E.</given-names></name><name><surname>Tulinius</surname><given-names>M.</given-names></name></person-group><article-title>The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities</article-title><source>Ann. Neurol.</source><year>2001</year><volume>49</volume><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">11261513</pub-id></citation></ref><ref id="bib5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uusimaa</surname><given-names>J.</given-names></name><name><surname>Moilanen</surname><given-names>J.S.</given-names></name><name><surname>Vainionpaa</surname><given-names>L.</given-names></name><name><surname>Tapanainen</surname><given-names>P.</given-names></name><name><surname>Lindholm</surname><given-names>P.</given-names></name><name><surname>Nuutinen</surname><given-names>M.</given-names></name><name><surname>Lopponen</surname><given-names>T.</given-names></name><name><surname>Maki-Torkko</surname><given-names>E.</given-names></name><name><surname>Rantala</surname><given-names>H.</given-names></name><name><surname>Majamaa</surname><given-names>K.</given-names></name></person-group><article-title>Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A&#x0003e;G mutation in children</article-title><source>Ann. Neurol.</source><year>2007</year><volume>62</volume><fpage>278</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">17823937</pub-id></citation></ref><ref id="bib6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>A.M.</given-names></name><name><surname>McFarland</surname><given-names>R.</given-names></name><name><surname>Blakely</surname><given-names>E.L.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Whittaker</surname><given-names>R.G.</given-names></name><name><surname>Taylor</surname><given-names>R.W.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name></person-group><article-title>Prevalence of mitochondrial DNA disease in adults</article-title><source>Ann Neurol.</source><year>2008</year><volume>63</volume><fpage>35</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">17886296</pub-id></citation></ref><ref id="bib7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shoubridge</surname><given-names>E.A.</given-names></name><name><surname>Wai</surname><given-names>T.</given-names></name></person-group><article-title>Mitochondrial DNA and the mammalian oocyte</article-title><source>Curr. Top. Dev. Biol.</source><year>2007</year><volume>77</volume><fpage>87</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">17222701</pub-id></citation></ref><ref id="bib8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>R.W.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name></person-group><article-title>Mitochondrial DNA mutations in human disease</article-title><source>Nat. Rev. Genet.</source><year>2005</year><volume>6</volume><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">15861210</pub-id></citation></ref><ref id="bib9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cree</surname><given-names>L.M.</given-names></name><name><surname>Samuels</surname><given-names>D.C.</given-names></name><name><surname>Chuva de Sousa Lopes</surname><given-names>S.</given-names></name><name><surname>Rajasimha</surname><given-names>H.K.</given-names></name><name><surname>Wonnapinij</surname><given-names>P.</given-names></name><name><surname>Mann</surname><given-names>J.R.</given-names></name><name><surname>Dahl</surname><given-names>H.-H.M.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name></person-group><article-title>A reduction in the number of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes</article-title><source>Nat. Genet.</source><year>2007</year><volume>40</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">18223651</pub-id></citation></ref><ref id="bib10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>N.</given-names></name></person-group><article-title>Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve?</article-title><source>J. Bioenerg. Biomembr.</source><year>1997</year><volume>29</volume><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">9239541</pub-id></citation></ref><ref id="bib11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Achilli</surname><given-names>A.</given-names></name><name><surname>Valentino</surname><given-names>M.L.</given-names></name><name><surname>Rengo</surname><given-names>C.</given-names></name><name><surname>Semino</surname><given-names>O.</given-names></name><name><surname>Pala</surname><given-names>M.</given-names></name><name><surname>Olivieri</surname><given-names>A.</given-names></name><name><surname>Mattiazzi</surname><given-names>M.</given-names></name><name><surname>Pallotti</surname><given-names>F.</given-names></name><name><surname>Carrara</surname><given-names>F.</given-names></name></person-group><article-title>Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees</article-title><source>Am. J. Hum. Genet.</source><year>2006</year><volume>78</volume><fpage>564</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">16532388</pub-id></citation></ref><ref id="bib12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chase</surname><given-names>D.S.</given-names></name><name><surname>Tawn</surname><given-names>E.J.</given-names></name><name><surname>Parker</surname><given-names>L.</given-names></name><name><surname>Jonas</surname><given-names>P.</given-names></name><name><surname>Parker</surname><given-names>C.O.</given-names></name><name><surname>Burn</surname><given-names>J.</given-names></name></person-group><article-title>The North Cumbria Community Genetics Project</article-title><source>J. Med. Genet.</source><year>1998</year><volume>35</volume><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">9610806</pub-id></citation></ref><ref id="bib13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Relton</surname><given-names>C.L.</given-names></name><name><surname>Daniel</surname><given-names>C.P.</given-names></name><name><surname>Hammal</surname><given-names>D.M.</given-names></name><name><surname>Parker</surname><given-names>L.</given-names></name><name><surname>Janet Tawn</surname><given-names>E.</given-names></name><name><surname>Burn</surname><given-names>J.</given-names></name></person-group><article-title>DNA repair gene polymorphisms, pre-natal factors and the frequency of somatic mutations in the glycophorin-A gene among healthy newborns</article-title><source>Mutat. Res.</source><year>2004</year><volume>545</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">14698416</pub-id></citation></ref><ref id="bib14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torroni</surname><given-names>A.</given-names></name><name><surname>Huoponen</surname><given-names>K.</given-names></name><name><surname>Francalacci</surname><given-names>P.</given-names></name><name><surname>Petrozzi</surname><given-names>M.</given-names></name><name><surname>Morelli</surname><given-names>L.</given-names></name><name><surname>Scozzari</surname><given-names>R.</given-names></name><name><surname>Obinu</surname><given-names>D.</given-names></name><name><surname>Savontaus</surname><given-names>M.L.</given-names></name><name><surname>Wallace</surname><given-names>D.C.</given-names></name></person-group><article-title>Classification of European mtDNAs from an analysis of three European populations</article-title><source>Genetics</source><year>1996</year><volume>144</volume><fpage>1835</fpage><lpage>1850</lpage><pub-id pub-id-type="pmid">8978068</pub-id></citation></ref><ref id="bib15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>R.W.</given-names></name><name><surname>Durham</surname><given-names>S.E.</given-names></name><name><surname>Deschauer</surname><given-names>M.</given-names></name><name><surname>Schaefer</surname><given-names>A.M.</given-names></name><name><surname>Samuels</surname><given-names>D.C.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name></person-group><article-title>Depletion of mitochondrial DNA in leucocytes harbouring the 3243A-&#x0003e;G mtDNA mutation</article-title><source>J. Med. Genet.</source><year>2007</year><volume>44</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">16950816</pub-id></citation></ref><ref id="bib16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>R.M.</given-names></name><name><surname>Kubacka</surname><given-names>I.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Lightowlers</surname><given-names>R.N.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name><name><surname>Howell</surname><given-names>N.</given-names></name></person-group><article-title>Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA</article-title><source>Nat. Genet.</source><year>1999</year><volume>23</volume><fpage>147</fpage><pub-id pub-id-type="pmid">10508508</pub-id></citation></ref><ref id="bib17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuels</surname><given-names>D.C.</given-names></name><name><surname>Carothers</surname><given-names>A.D.</given-names></name><name><surname>Horton</surname><given-names>R.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name></person-group><article-title>The power to detect disease associations with mitochondrial DNA haplogroups</article-title><source>Am. J. Hum. Genet.</source><year>2006</year><volume>78</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">16532401</pub-id></citation></ref><ref id="bib18"><label>18</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>P.</given-names></name><name><surname>Berry</surname><given-names>G.</given-names></name><name><surname>Matthews</surname><given-names>J.N.S.</given-names></name></person-group><article-title>Statistical Methods in Medical Research</article-title><edition>Fourth Edition</edition><year>2002</year><publisher-name>Blackwell</publisher-name><publisher-loc>Oxford</publisher-loc></citation></ref><ref id="bib19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>P.Y.</given-names></name><name><surname>Griffiths</surname><given-names>P.G.</given-names></name><name><surname>Brown</surname><given-names>D.T.</given-names></name><name><surname>Howell</surname><given-names>N.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name></person-group><article-title>The epidemiology of leber hereditary optic neuropathy in the north East of England</article-title><source>Am. J. Hum. Genet.</source><year>2003</year><volume>72</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">12518276</pub-id></citation></ref><ref id="bib20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manwaring</surname><given-names>N.</given-names></name><name><surname>Jones</surname><given-names>M.M.</given-names></name><name><surname>Wang</surname><given-names>J.J.</given-names></name><name><surname>Rochtchina</surname><given-names>E.</given-names></name><name><surname>Howard</surname><given-names>C.</given-names></name><name><surname>Mitchell</surname><given-names>P.</given-names></name><name><surname>Sue</surname><given-names>C.M.</given-names></name></person-group><article-title>Population prevalence of the MELAS A3243G mutation</article-title><source>Mitochondrion</source><year>2007</year><volume>7</volume><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">17300999</pub-id></citation></ref><ref id="bib21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajasimha</surname><given-names>H.K.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Samuels</surname><given-names>D.C.</given-names></name></person-group><article-title>Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A--&#x0003e;G mutation in blood</article-title><source>Am. J. Hum. Genet.</source><year>2008</year><volume>82</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">18252214</pub-id></citation></ref><ref id="bib22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>'t Hart</surname><given-names>L.M.</given-names></name><name><surname>Jansen</surname><given-names>J.J.</given-names></name><name><surname>Lemkes</surname><given-names>H.H.P.J.</given-names></name><name><surname>de Knijff</surname><given-names>P.</given-names></name><name><surname>Maassen</surname><given-names>J.A.</given-names></name></person-group><article-title>Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging</article-title><source>Hum. Mutat.</source><year>1996</year><volume>7</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">8829651</pub-id></citation></ref><ref id="bib23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemm</surname><given-names>T.</given-names></name><name><surname>Neumann</surname><given-names>S.</given-names></name><name><surname>Trulzsch</surname><given-names>B.</given-names></name><name><surname>Pistrosch</surname><given-names>F.</given-names></name><name><surname>Hanefeld</surname><given-names>M.</given-names></name><name><surname>Paschke</surname><given-names>R.</given-names></name></person-group><article-title>Search for mitochondrial DNA mutation at position 3243 in German patients with a positive family history of maternal diabetes mellitus</article-title><source>Exp. Clin. Endocrinol. Diabetes</source><year>2001</year><volume>109</volume><fpage>283</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">11507652</pub-id></citation></ref><ref id="bib24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torroni</surname><given-names>A.</given-names></name><name><surname>Petrozzi</surname><given-names>M.</given-names></name><name><surname>D'Urbano</surname><given-names>L.</given-names></name><name><surname>Sellitto</surname><given-names>D.</given-names></name><name><surname>Zeviani</surname><given-names>M.</given-names></name><name><surname>Carrara</surname><given-names>F.</given-names></name><name><surname>Carducci</surname><given-names>C.</given-names></name><name><surname>Leuzzi</surname><given-names>V.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Barboni</surname><given-names>P.</given-names></name></person-group><article-title>Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484</article-title><source>Am. J. Hum. Genet.</source><year>1997</year><volume>60</volume><fpage>1107</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">9150158</pub-id></citation></ref><ref id="bib25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>G.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Spruijt</surname><given-names>L.</given-names></name><name><surname>Gerards</surname><given-names>M.</given-names></name><name><surname>Mowbray</surname><given-names>C.</given-names></name><name><surname>Achilli</surname><given-names>A.</given-names></name><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Elson</surname><given-names>J.</given-names></name><name><surname>Howell</surname><given-names>N.</given-names></name><name><surname>La Morgia</surname><given-names>C.</given-names></name></person-group><article-title>Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background</article-title><source>Am. J. Hum. Genet.</source><year>2007</year><volume>81</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">17668373</pub-id></citation></ref><ref id="bib26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuels</surname><given-names>D.C.</given-names></name><name><surname>Boys</surname><given-names>R.J.</given-names></name><name><surname>Henderson</surname><given-names>D.A.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name></person-group><article-title>A compositional segmentation of the human mitochondrial genome is related to heterogeneities in the guanine mutation rate</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>6043</fpage><lpage>6052</lpage><pub-id pub-id-type="pmid">14530452</pub-id></citation></ref><ref id="bib27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M.</given-names></name></person-group><article-title>Solution of a Process of Random Genetic Drift with a Continuous Model</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1955</year><volume>41</volume><fpage>144</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">16589632</pub-id></citation></ref><ref id="bib28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>K.</given-names></name><name><surname>Elliott</surname><given-names>H.R.</given-names></name><name><surname>Keers</surname><given-names>S.M.</given-names></name><name><surname>Lambert</surname><given-names>C.</given-names></name><name><surname>Pyle</surname><given-names>A.</given-names></name><name><surname>Graves</surname><given-names>T.D.</given-names></name><name><surname>Woodward</surname><given-names>C.</given-names></name><name><surname>Sweeney</surname><given-names>M.G.</given-names></name><name><surname>Davis</surname><given-names>M.B.</given-names></name><name><surname>Hanna</surname><given-names>M.G.</given-names></name></person-group><article-title>Episodic ataxia and hemiplegia caused by the 8993T-&#x0003e;C mitochondrial DNA mutation</article-title><source>J. Med. Genet.</source><year>2007</year><volume>44</volume><fpage>797</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">18055910</pub-id></citation></ref><ref id="bib29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odawara</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>K.</given-names></name><name><surname>Yamashita</surname><given-names>K.</given-names></name></person-group><article-title>Prevalence and clinical characterisation of Japanese diabetes mellitus with an A-to-G mutation at nucleotide 3243 of the mitochondrial tRNALeu(UUR) gene</article-title><source>J. Clin. Endocrinol. Metab.</source><year>1995</year><volume>80</volume><fpage>1290</fpage><lpage>1294</lpage><pub-id pub-id-type="pmid">7714102</pub-id></citation></ref><ref id="bib30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newkirk</surname><given-names>J.E.</given-names></name><name><surname>Taylor</surname><given-names>R.W.</given-names></name><name><surname>Howell</surname><given-names>N.</given-names></name><name><surname>Bindoff</surname><given-names>L.A.</given-names></name><name><surname>Chinnery</surname><given-names>P.F.</given-names></name><name><surname>Alberti</surname><given-names>K.G.</given-names></name><name><surname>Turnbull</surname><given-names>D.M.</given-names></name><name><surname>Walker</surname><given-names>M.</given-names></name></person-group><article-title>Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population</article-title><source>Diabet. Med.</source><year>1997</year><volume>14</volume><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">9212310</pub-id></citation></ref><ref id="bib31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>L.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name></person-group><article-title>Prevalence and clinical characteristics of mitochondrial tRNAleu(UUR) nt 3243 A--&#x0003e;G and nt 3316 G--&#x0003e;A mutations in Chinese patients with type 2 diabetes</article-title><source>Diabetes Res. Clin. Pract.</source><year>2001</year><volume>54</volume><issue>Suppl 2</issue><fpage>S35</fpage><lpage>S38</lpage><pub-id pub-id-type="pmid">11733107</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Percentage of Mutated mtDNA in the 15 Mutation-Positive Cases</p><p>Red: m.14484T&#x02192;C; blue: m.11778G&#x02192;A; green: m.3460G&#x02192;A; black: m.3243A&#x02192;G; orange: m.1555A&#x02192;G.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>mtDNA Haplogroup Distribution in 344 Random Umbilical-Cord-Blood Samples from North Cumbria, England</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="11"><bold>mtDNA Haplogroup</bold><hr/></th></tr><tr><th/><th><bold>H</bold></th><th><bold>U</bold></th><th><bold>T</bold></th><th><bold>J</bold></th><th><bold>W</bold></th><th><bold>V</bold></th><th><bold>I</bold></th><th><bold>X</bold></th><th><bold>M</bold></th><th><bold>Other</bold></th><th><bold>Total</bold></th></tr></thead><tbody><tr><td>n</td><td>137</td><td>79</td><td>45</td><td>34</td><td>14</td><td>12</td><td>7</td><td>7</td><td>1</td><td>8</td><td>344</td></tr><tr><td>%</td><td>39.83</td><td>22.97</td><td>13.08</td><td>9.88</td><td>4.07</td><td>3.49</td><td>2.03</td><td>2.03</td><td>0.29</td><td>2.33</td><td>100</td></tr><tr><td>95% CI</td><td>34.61&#x02013;45.21</td><td>18.62&#x02013;27.78</td><td>9.70&#x02013;17.11</td><td>6.90&#x02013;13.54</td><td>2.24&#x02013;6.73</td><td>1.82&#x02013;6.01</td><td>0.82&#x02013;4.15</td><td>0.82&#x02013;4.15</td><td>&#x0003c; 0.01&#x02013;1.61</td><td>1.01&#x02013;4.53</td><td/></tr></tbody></table><table-wrap-foot><fn><p>95% CI &#x0003d; Exact 95% confidence interval. The haplogroup U data includes the K subgroup. There were 27 subjects who belonged to the K subgroup of haplogroup U (K &#x0003d; 7.85% of the entire control cohort, 95% CI &#x0003d; 5.24&#x02013;11.21).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>The Frequency of Ten Pathogenic mtDNA Mutations in North Cumbria, England</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>mtDNA Mutation</td><td>1555A&#x02192;G</td><td>3243A&#x02192;G</td><td>3460G&#x02192;A</td><td>7445A&#x02192;G</td><td>8344A&#x02192;G</td><td>8993T&#x02192;G</td><td>11778G&#x02192;A</td><td>13513G&#x02192;A</td><td>14459G&#x02192;A</td><td>14484T&#x02192;C</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td>Positive Calls</td><td>2</td><td>4</td><td>3</td><td>0</td><td>0</td><td>0</td><td>3</td><td>0</td><td>0</td><td>3<xref rid="tblfn1" ref-type="table-fn">a</xref></td></tr><tr><td colspan="11"><hr/></td></tr><tr><td/><td>4755-1 T (4.4%),</td><td>4394-1 H (32.7%),</td><td>2728-1 T (18.4%),</td><td/><td/><td/><td>3530-1 K (100.0%),</td><td/><td/><td><xref rid="tblfn1" ref-type="table-fn">a</xref>4607-1 J (100.0%),</td></tr><tr><td>MtDNA Haplogroup<xref rid="tblfn2" ref-type="table-fn">b</xref></td><td>5798-1 J (4.4%)</td><td>5218-1 H (10.2%),</td><td>2916-1 H (42.5%),</td><td/><td/><td/><td>5841-1 H (74.8%),</td><td/><td/><td><xref rid="tblfn1" ref-type="table-fn">a</xref>0493-1 J (100.0%),</td></tr><tr><td>(Percentage of Mutated mtDNA)</td><td/><td>5130-1 U (1.7%),</td><td>0060-1 H (12.9%)</td><td/><td/><td/><td>0282-1 K (56.5%)</td><td/><td/><td>2966-1 J (89.1%)</td></tr><tr><td/><td/><td>5025-1 H (0.5%)</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td colspan="11"><hr/></td></tr><tr><td>No. of Successful Genotypes</td><td>2751</td><td>2810</td><td>2807</td><td>2907</td><td>2770</td><td>2835</td><td>2770</td><td>2717</td><td>2676</td><td>2855</td></tr><tr><td colspan="11"><hr/></td></tr><tr><td>Frequency %</td><td>0.07</td><td>0.14</td><td>0.11</td><td>0</td><td>0</td><td>0</td><td>0.11</td><td>0</td><td>0</td><td>0.11</td></tr><tr><td>(95% CI)</td><td>(0.01&#x02013;0.26)</td><td>(0.04&#x02013;0.36)</td><td>(0.02&#x02013;0.31)</td><td>(0&#x02013;0.13)</td><td>(0&#x02013;0.13)</td><td>(0&#x02013;0.13)</td><td>(0.02&#x02013;0.32)</td><td>(0&#x02013;0.14)</td><td>(0&#x02013;0.14)</td><td>(0.02&#x02013;0.31)</td></tr></tbody></table><table-wrap-foot><fn><p>For nine mutations, the percentage of mutated mtDNA was determined by last-cycle fluorescent PCR. For m.1555A&#x02192;G, heteroplasmy was quantified by cloning and sequencing of independent mtDNA fragments. The detection threshold for the m.1555A&#x02192;G mutation could not be quantified because of a lack of an efficient fluorescent RFLP assay. However, dilution curves similar to those demonstrated estimated the assay to be efficient in detecting low levels of heteroplasmy. Quantification by cloning and sequencing of mtDNA fragments of the lowest dilution positively identified by MALDI-TOF MS indicated that the threshold of detection for m.1555A&#x02192;G was 1.4% (1 of 70 independent clones).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p>Two of these three subjects were known to be siblings. CI denotes confidence interval.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn2"><label>b</label><p>MtDNA haplogroup refers to the individual positive cases and their associated mtDNA haplogroup. The number is the case identifier; the letter refers to the European mtDNA haplogroup. K indicates the K subgroup of haplogroup U.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>mtDNA D-Loop Sequence for the Mutation-Positive Cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><bold>Subject ID</bold></th><th rowspan="2">rCRS</th><th colspan="2"><bold>1555A&#x02192;G</bold><hr/></th><th colspan="8"><bold>3243A&#x02192;G</bold><hr/></th><th colspan="4"><bold>14484T&#x02192;C</bold><hr/></th><th colspan="3"><bold>3460G&#x02192;A</bold><hr/></th><th colspan="5"><bold>11778G&#x02192;A</bold><hr/></th></tr><tr><th>4755-1</th><th>5798-1</th><th>4394-1</th><th><bold>4394-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>5218-1</th><th><bold>5218-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>5130-1</th><th><bold>5130-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>5025-1</th><th><bold>5025-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>4607-1</th><th><bold>4607-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>0493-1</th><th>02966</th><th>02728</th><th>02916</th><th>00060</th><th>3530-1</th><th><bold>3530-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>5841-1</th><th><bold>5841-0</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></th><th>00282</th></tr></thead><tbody><tr><td><bold>Haplogroup</bold></td><td>H</td><td>T</td><td>J</td><td>H</td><td>H</td><td>H</td><td>H</td><td>U</td><td>U</td><td>H</td><td>H</td><td>J</td><td>J</td><td>J</td><td>J</td><td>T</td><td>H</td><td>H</td><td>K</td><td>K</td><td>H</td><td>H</td><td>K</td></tr><tr><td colspan="24"><bold>mtDNA np</bold></td></tr><tr><td>22</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>73</td><td>A</td><td>G</td><td>G</td><td>-</td><td>-</td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td>G</td><td>G</td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>G</td></tr><tr><td>150</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>152</td><td>T</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>-</td><td>C</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td></tr><tr><td>195</td><td>T</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>200</td><td>A</td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>228</td><td>G</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>242</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>263</td><td>A</td><td>G</td><td>G</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td>G</td><td>G</td><td>G</td><td>G</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>G</td></tr><tr><td>295</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>T</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>309</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>309 Ins&#x0002b;1</td><td>-</td><td>C</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>T</td><td>-</td><td>-</td><td>-</td><td>C</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td></tr><tr><td>309 Ins&#x0002b;2</td><td>-</td><td>-</td><td>-</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td></tr><tr><td>315</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>315 Ins&#x0002b;1</td><td>-</td><td>C</td><td>C</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>C</td><td>C</td><td>C</td><td>C</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td></tr><tr><td>319</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>462</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>482</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>489</td><td>T</td><td>-</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>497</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>T</td></tr><tr><td>513</td><td>G</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td><bold>A</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>525</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>525 Ins&#x0002b;1</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td></tr><tr><td>525 Ins&#x0002b;2</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td><bold>A</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td></tr><tr><td>525 Ins&#x0002b;3</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td></tr><tr><td>525 Ins&#x0002b;4</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td><bold>A</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td></tr><tr><td>15833</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>15928</td><td>G</td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16069</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>T</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16093</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td></tr><tr><td>16126</td><td>T</td><td>C</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>C</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16129</td><td>G</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td><bold>A</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td></tr><tr><td>16145</td><td>G</td><td>-</td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>A</td><td><bold>A</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16163</td><td>A</td><td>G</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16172</td><td>T</td><td>-</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16186</td><td>C</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16189</td><td>T</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16192</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16222</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16224</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>C</td></tr><tr><td>16231</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16240</td><td>A</td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16261</td><td>C</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16294</td><td>C</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16296</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16304</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td>-</td><td>C</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16311</td><td>T</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>C</td></tr><tr><td>16316</td><td>A</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>G</td><td><bold>G</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td></tr><tr><td>16360</td><td>C</td><td>-</td><td>-</td><td>T</td><td><bold>T</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>16519</td><td>T</td><td>C</td><td>-</td><td>C</td><td><bold>C</bold></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>-</td><td>-</td><td>-</td><td>-</td><td>C</td><td>C</td><td>-</td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td><td><bold>C</bold><xref rid="tblfn3" ref-type="table-fn">a</xref></td><td>C</td></tr></tbody></table><table-wrap-foot><fn><p>rCRS indicates nucleotide present in the revised Cambridge reference sequence for mtDNA.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p><p>np indicates &#x0201c;nucleotide pair,&#x0201d; numbered according to the rCRS.</p><p>Dashes indicate rCRS nucleotides.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn3"><label>a</label><p>Matched maternal samples.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 